US · Healthcare

TC Biopharm (Holdings) Plc (TCBPY)

Biotechnology

TC Biopharm (Holdings) Plc (TCBPY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TCBPY

P/E ratio

25.00

TC Biopharm (Holdings) Plc (TCBPY) — FAQ

What is TCBPY's P/E ratio?

The price-to-earnings (P/E) ratio for TC Biopharm (Holdings) Plc (TCBPY) is 25.00 (data as of 2026-05-23).

Does TC Biopharm (Holdings) Plc pay a dividend?

Dividend yield is not available in the current snapshot for TC Biopharm (Holdings) Plc (TCBPY). Check the MyAverix Finance app for the latest dividend data.

What sector is TC Biopharm (Holdings) Plc in?

TC Biopharm (Holdings) Plc (TCBPY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is TCBPY listed on?

TCBPY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)